Background Mortality from cardiac surgery is an essential indicator of quality and forms the basis of treatment strategy decisions in eligible patients. No contemporary complete data on unselected adult cardiac surgery patients are available in Germany.
Introduction
Exact estimates of operative risk are essential for the choice of treatment strategy in cardiac patients eligible for surgical therapy. From earlier registries, mortality after bypass surgery has been reported to be in the magnitude of 3·7 to 6·4% [1, 2] . In selected subgroups of patients in randomized studies, the risk was reported to be 1·3 to 3·2% [3, 4] . In Germany, the Society for Thoracic and Cardiovascular Surgery launched a multicentre registry for the quality assurance of cardiac surgery in 1986, but no complete data on 30-day mortality have been reported to date [5, 6] . The main reason is incomplete follow-up of the patients after discharge from hospital. The Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) initiated a registry in June 1997 aimed at recording all patients referred to surgery from the 85 centres. The main outcome variable was 30-day mortality, for which surprisingly no exact figures are available in Germany, even though it is the country with the highest number of procedures in Europe. The registry was closed in March 1998 after more than 10 000 patients had been entered.
Methods
All patients referred to cardiac surgery with any diagnosis from the 85 participating centres of cardiology were centrally recorded by means of a simple one-page entry form. This included the patients' personal data, age, sex, and the operation planned. Clinical data were restricted to classification of symptoms (NYHA, CCS), extent of coronary disease (1-, 2-or 3-vessel or left main disease), and the number of previous procedures (PTCA or surgery). Integral to the registry was a pre-operative estimate of the risk by the cardiologist and/or the cardiac surgeon in five classes of operative mortality (0-2%, 3-5%, 6-10%, 11-25%, >25%). This estimate was not to be given by reference to a common score system but by intuitive clinical judgement.
The patients received written information on the purpose of the registry and a short questionnaire to be returned to the data centre in Kassel 1 month after the operation had been performed. The questionnaire contained the date of the operation, information on severe complications (myocardial infarction, cerebrovascular attack, other severe complication), and a short statement as to whether the patient felt better, worse or unchanged compared to the pre-operative state. If the questionnaire was not returned within 42 days after the planned date of the intervention, a letter was sent to the patient from the data centre asking the same questions. If no answer was received within 2 weeks, the patient or his family was contacted by phone. If this was not possible, further follow-up of the data was done by contacting the family physician or the cardiology centre originally treating the patient. By these combined efforts, eventually all but one patient could be followed, at least with respect to their vital status.
Data in the text are given as means standard deviation or, where appropriate, as median values and 25%-75% percentiles. A multivariate analysis of the determinants of mortality was done with logistic regression, the results of which are expressed as odds ratios with 95% confidence intervals. The database was programmed in dBase. All statistical calculations were done with CSS STATISTICA by StatSoft.
Results

Data entry and completion
From June 1997 to the end of March 1998 11 350 patients were entered into the registry, of which all but one data set could be completed at the time of writing (99·99% complete). Nineteen percent of patients returned the questionnaire, 52% responded to the letter, and 29% responded to telephone prompting. Figure 1 shows the time course of data completion in relation to the time of surgery.
Patient characteristics and operations performed
The patients were aged 65·4 9·6 years; 28·2% were women. Of the interventions, 8853 included coronary revascularization, 2314 valve replacement, and 343 other interventions. Angina pectoris of CCS class III or IV was present in 4457 patients; 2006 patients had symptoms of heart failure NYHA class III or IV. Previous coronary angioplasty had been performed in 1221 patients, and 566 had had one or more previous cardiac operations. The pre-operative risk estimate was completed in 99·6% of the patients. The average risk estimate was 3·9 3·5% (calculated by assigning the arithmetic mean of each risk-interval to the estimates and 25 to the highest class), 307 patients were estimated to have a risk >10%. The risk estimates were suggested by cardiologists in 8956 patients, and by conferring with the cardiac surgeons in 1423. Eight hundred and twenty-four of the patients in the registry did not subsequently undergo surgery for various reasons, and 134 of them died. These patients were 66·2 10·2 years old, and 28% were female. Ninety-five of the patients (11·5%) were scheduled for complex surgery (combined bypass and valve surgery or double valve replacement). The pre-operative risk estimate was >10% in 67 patients, and 328 patients (39%) in NYHA class >II had signs of cardiac failure or left ventricular ejection fraction <40%. Further data in this paper only refers to the patients who underwent operation. 
Mortality and complications
The cumulative mortality of the patients is given in Fig.  2 . Of 10 525 patients, 491 died (4·67%). By 30 days postoperative mortality was 3·91%. Seventy-nine patients died after more than 30 days. Of those deaths, 69 were causally related to the intervention. The total operative mortality was therefore 4·57%. The mortality figures, broken down by different surgical procedures, are given in Table 1 . Valve surgery carried a higher risk that isolated coronary revascularization; the increase in risk is mainly due to the high risk of mitral valve replacement, especially in combination with bypass surgery. Multivariate analysis was performed for predictors of death including the following factors: age >75 years, female gender, left main disease, 3-vessel disease, angina of CCS class IV, evidence of NYHA class dIII cardiac failure, or left ventricular ejection fraction <0·4, repeat cardiac operation, emergency operation, and complex surgical procedure defined as revascularization with valve replacement or double valve surgery. The results of this analysis are given in Table 2 . The most powerful predictors of death were repeat and emergency cardiac operation, followed by older age and signs of cardiac failure.
Some variation in mortality was also seen between the participating centres. To reduce the influence of chance, centres with <100 patients were excluded from this analysis. The operative morality ranged from 0·9% to 10·7% in 43 centres with more than 100 patients. Most, but not all, of these differences are explained by different patients characteristics in terms of the factors described above. Using multivariate analysis including the same factors as before, in addition to the centre of origin of the patients, we could identify several centres with significantly higher mortality than average. We could not, however, identify any centre with a significantly lower mortality than the rest of the registry. The highest multivariate odds ratio of death for a specific centre was 1·65 (95% CI 1·26-2·15). This analysis is, however, limited by the simplicity of the data evaluated, with more detailed clinical information omitted on concomitant disease and other clinically relevant factors. Figure 3 depicts the observed mortality broken down by the pre-operative estimate in five classes. In none of the five risk classes is the observed risk outside the predicted range. In the lower risk groups representing the majority of the patients the observed risk is at the upper end of the predicted range. It seems that no patient group with a risk clearly below 2% can be identified, which may therefore be interpreted as the baseline risk of cardiac surgery even in patients with favourable clinical characteristics.
Pre-operative estimate vs observed morality
Discussion
The data in this registry are the first complete survey of 30-day surgical mortality in a representative number of women Figure 2 Cumulative mortality was 3·91% at 30 days after cardiac surgery; few patients died later from operative complications. Mortality in women was clearly higher than in men, but this was mainly due to their older age (68·5 9·2 vs 64·0 9·3 years, P<0·001). In the multivariate analysis, there was only a small increase in mortality in women as compared to men. all cardiac surgical procedures in Germany. The overall mortality figures are within the range of earlier reports from the United States [1] and a recent report from the United Kingdom [2] , but these previous data are restricted to patients with coronary revascularization. Subgroups of randomized studies of bypass surgery had lower mortality rates, but these groups were highly selected by protocol [3, 4] . A recent report on mortality from cardiac surgery in Germany, based on questionnaires sent to the German cardiothoracic surgery centres, reports slightly lower mortality rates for 1997 [7] . These figures refer to hospital mortality only, and no complete 30-day mortality is available.
Predictors of operative mortality were the procedural factors of repeat, emergency or complex surgery and the clinical factors age, gender, cardiac failure and extent of coronary disease. Mitral valve replacement, especially in combination with coronary revascularization, carried the highest risk. Although statistically significant in multivariate analysis, the increase in risk by any of these factors was small. The highest odds ratio of 2·35 (1·91-2·98) was found for repeat cardiac surgery, indicating an approximate doubling of risk as compared to a first operation. Given the low baseline risk, these factors alone are certainly not sufficient to explain the wide variations in mortality between the groups assigned to by pre-operative risk assessment. The clinical judgement clearly involved many more factors than recorded in this registry, leading to remarkably correct prediction of the operative mortality without reference to a score system. It might have been of interest to compare the clinical prediction made here with other risk stratification systems. This was impossible, however, since no data were recorded of concomitant disease (pulmonary, renal, diabetes) and other functional parameters necessary to complete the traditional score systems.
We found some variations in the mortality figures from different participating centres. In centres with >100 patients, where the play of chance should be limited, the operative mortality varied from 0·9 to 10·7%, which was not fully explained by differences in the risk factors analysed. This may be interpreted as indicating a lack of quality. This interpretation, however, is not conclusive, since many other factors of proven predictive value are not recorded in this registry. Therefore, further investigations should be done in centres with significantly higher than average mortality to uncover potential quality deficiencies.
This registry has two important limitations. First, although the patients entered in the registry have been followed so that the responses were nearly 100% complete, we cannot be sure that every patient referred to surgery from the participating centres was recorded, giving rise to a potential selection bias. This possibility could only have been excluded by local audits which were not part of this project. Second, to assure completeness of the data, the data set had to be reduced to a minimum. This was only possible if important information on concomitant disease, indicators of severity other than those described, and many other clinical items were omitted. Despite these limitations, the registry may form a basis for quality control in recording the outcome of cardiac surgery. Figure 3 Predicted vs observed mortality from cardiac surgery. The prediction was remarkably reliable for the five risk groups.
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